Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lance Cowey

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Lung Cancer (Amsterdam, Netherlands)|June 4, 2014
BRAF V600E-mutated lung adenocarcinoma with metastases to the brain responding to treatment with vemurafenibSara D Robinson, Joyce A O'Shaughnessy, C Lance Cowey, et al.
Cancers|October 27, 2019
Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for <i>BRAF</i>-Mutant MelanomaOmid Hamid, C Lance Cowey, Michelle Offner, et al.
Medicine|July 16, 2019
Real-world treatment patterns and clinical outcomes among patients with advanced melanoma: A retrospective, community oncology-based cohort study (A STROBE-compliant article)C Lance Cowey, Frank Xiaoqing Liu, Marley Boyd, et al.
Future Oncology (London, England)|June 14, 2017
Real-world treatment outcomes in patients with metastatic Merkel cell carcinoma treated with chemotherapy in the USAC Lance Cowey, Lisa Mahnke, Janet Espirito, et al.
Plos One|June 1, 2014
HIF1α and HIF2α exert distinct nutrient preferences in renal cellsAlexandra Arreola, C Lance Cowey, Jonathan L Coloff, et al.
Nuclear Medicine Communications|June 21, 2012
Primary renal cell carcinoma: relationship between 18F-FDG uptake and response to neoadjuvant sorafenibAmir H Khandani, C Lance Cowey, Dominic T Moore, et al.
Critical Reviews in Oncology/Hematology|August 14, 2010
Sequential use of targeted agents in the treatment of renal cell carcinomaThomas E Hutson, Ronald M Bukowski, C Lance Cowey, et al.
Cancer Medicine|June 25, 2020
Clinical outcomes among unresectable, locally advanced, and metastatic cutaneous squamous cell carcinoma patients treated with systemic therapyC Lance Cowey, Nicholas J Robert, Janet L Espirito, et al.
The Oncologist|June 8, 2021
Real-World Clinical Outcomes in Patients with Locally Advanced or Metastatic Merkel Cell Carcinoma Treated in U.S. Oncology Clinical Practices: Results from SPEAR-MerkelAbhijeet Bhanegaonkar, Frank X Liu, Marley Boyd, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 19, 2017
Pembrolizumab Utilization and Outcomes for Advanced Melanoma in US Community Oncology PracticesC Lance Cowey, Frank Xiaoqing Liu, Jenny Black-Shinn, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Lung Cancer (Amsterdam, Netherlands)|June 4, 2014
BRAF V600E-mutated lung adenocarcinoma with metastases to the brain responding to treatment with vemurafenibSara D Robinson, Joyce A O'Shaughnessy, C Lance Cowey, et al.
Cancers|October 27, 2019
Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for <i>BRAF</i>-Mutant MelanomaOmid Hamid, C Lance Cowey, Michelle Offner, et al.
Medicine|July 16, 2019
Real-world treatment patterns and clinical outcomes among patients with advanced melanoma: A retrospective, community oncology-based cohort study (A STROBE-compliant article)C Lance Cowey, Frank Xiaoqing Liu, Marley Boyd, et al.
Future Oncology (London, England)|June 14, 2017
Real-world treatment outcomes in patients with metastatic Merkel cell carcinoma treated with chemotherapy in the USAC Lance Cowey, Lisa Mahnke, Janet Espirito, et al.
Plos One|June 1, 2014
HIF1α and HIF2α exert distinct nutrient preferences in renal cellsAlexandra Arreola, C Lance Cowey, Jonathan L Coloff, et al.
Nuclear Medicine Communications|June 21, 2012
Primary renal cell carcinoma: relationship between 18F-FDG uptake and response to neoadjuvant sorafenibAmir H Khandani, C Lance Cowey, Dominic T Moore, et al.
Critical Reviews in Oncology/Hematology|August 14, 2010
Sequential use of targeted agents in the treatment of renal cell carcinomaThomas E Hutson, Ronald M Bukowski, C Lance Cowey, et al.
Cancer Medicine|June 25, 2020
Clinical outcomes among unresectable, locally advanced, and metastatic cutaneous squamous cell carcinoma patients treated with systemic therapyC Lance Cowey, Nicholas J Robert, Janet L Espirito, et al.
The Oncologist|June 8, 2021
Real-World Clinical Outcomes in Patients with Locally Advanced or Metastatic Merkel Cell Carcinoma Treated in U.S. Oncology Clinical Practices: Results from SPEAR-MerkelAbhijeet Bhanegaonkar, Frank X Liu, Marley Boyd, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 19, 2017
Pembrolizumab Utilization and Outcomes for Advanced Melanoma in US Community Oncology PracticesC Lance Cowey, Frank Xiaoqing Liu, Jenny Black-Shinn, et al.
Pageof 5